A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 2 Diabetes Mellitus

NCT03338010 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

536

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: LY2963016
DRUG: Lantus®

Sponsor

Eli Lilly and Company